CVS Health (CVS)
(Delayed Data from NYSE)
$62.47 USD
+0.37 (0.60%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.49 +0.02 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CVS 62.47 +0.37(0.60%)
Will CVS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVS
3 Medical Stocks to Consider as Markets Take a Breather
Economy Heating Up on PCE for June
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
PCE Comes in Warmer Than Expected
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
CVS Health (CVS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for CVS
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
5 Dividend Stocks With Solid Returns And More Growth Ahead
CVS Health (CVS): Morgan Stanley Raises Price Target to $82 | CVS Stock News
CVS Health (CVS) Target Price Boosted by BofA Following Strong Q2 Results
Barclays Raises Price Target on CVS to $80, Maintains Overweight Rating | CVS Stock News